MedPath

Tasso Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing

Recruiting
Conditions
Serum Analytes
First Posted Date
2024-04-30
Last Posted Date
2024-05-02
Lead Sponsor
Tasso Inc.
Target Recruit Count
220
Registration Number
NCT06392269
Locations
🇺🇸

Tasso Research Clinic, Seattle, Washington, United States

A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

Not yet recruiting
Conditions
Neutropenia
Leukocytosis
Leukopenia
First Posted Date
2024-04-11
Last Posted Date
2024-05-21
Lead Sponsor
Tasso Inc.
Target Recruit Count
40
Registration Number
NCT06360952
Locations
🇺🇸

Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

ALT Routinely Recorded Remotely: A Comparator Study of Liver Function Tests Using the Tasso+ to Venipuncture.

Conditions
Elevated Alanine Transaminase (ALT)
First Posted Date
2022-02-28
Last Posted Date
2022-02-28
Lead Sponsor
Tasso Inc.
Target Recruit Count
80
Registration Number
NCT05259618
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

EvergreenHealth Research, Kirkland, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.